$322.7M in CY2024 Part D spend13.9M claims · 4.9M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Ezetimibe used for?
Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyper....
Is there a generic for Ezetimibe?
Yes. 12 ANDAs filed at FDA, 12 generic manufacturers currently shipping.
How much does my plan pay for Ezetimibe?
Across 329 Part D plans, Ezetimibe averages $0.073/unit (NADAC). Lowest available: $0.073/unit. Highest in distribution: $0.073/unit.
Is Ezetimibe on the FDA shortage list?
Ezetimibe has been discontinued by its manufacturer(s).
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.